A twice-yearly injection could transform HIV prevention, yet questions of access illuminate deeper dilemmas surrounding public financing, pharmaceutical pricing, and contracting global health funding. Al Jazeera’s Mikail Malik investigates the struggle over equitable distribution.
Published On 30 Sep 2026
Also Read
- Nvidia Stock Can Top $400 in 5 Years If One Assumption Holds Up
- UK Government Links Iran to RAF Fairford Incident, Says Prime Minister
- Deadly Landslides Strike Nepal Again, Forcing Helicopter Evacuations of Trekkers
- Treasury unveils new Default Loan Support Hub as Education Department data shows 9.3 million borrowers in default
